Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Signific

submitted by: mcgheekkm

Dr. S. Vincent Rajkumar, from the Division of Hematology at Mayo Clinic, discusses advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance and implications for recategorizing disease entities, which will be published in the October 2010 issue of Mayo Clinic Proceedings (Available at: